ReclutandoNCT06841354
Fichas verificables
Estudios clínicos que estamos siguiendo.
Selección editorial de registros activos con sedes declaradas en México. Cada ficha conserva el NCT, estado, fase, sponsor, elegibilidad visible y vínculo al registro original.
Alcance: no es un catálogo completo de todos los ensayos en México. El estado puede cambiar; la fuente oficial tiene prioridad.
Cáncer de mama
ReclutandoNCT06926868
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Ver ficha informativaReclutandoNCT05646862
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
Ver ficha informativaCáncer de próstata
ReclutandoNCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Ver ficha informativaReclutandoNCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Ver ficha informativaCáncer de pulmón
ReclutandoNCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ver ficha informativaReclutandoNCT05899608
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Ver ficha informativaReclutandoNCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Ver ficha informativaMelanoma
ReclutandoNCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Ver ficha informativaDiabetes tipo 2
ReclutandoNCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ver ficha informativaReclutandoNCT07797335
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Ver ficha informativaAún no reclutaNCT07628985
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
Ver ficha informativaInsuficiencia cardiaca
ReclutandoNCT07567001
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Ver ficha informativaReclutandoNCT06008197
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Ver ficha informativaReclutandoNCT06424288
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Ver ficha informativaFibrilación auricular
ReclutandoNCT05712200
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Ver ficha informativaParkinson
ReclutandoNCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Ver ficha informativaParkinson y neurodegeneración
ReclutandoNCT06528964
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Ver ficha informativaDeterioro cognitivo leve
ReclutandoNCT07818369
Synbiotic LA-5 and Agave Inulin for Mild Cognitive Impairment
Ver ficha informativaReclutandoNCT06467253